Human cytomegalovirus and autoimmune disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Halenius, Anne ^a   Hengel, Hartmut ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; COMPLEMENT COMPONENT C3D; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65; HLA A ANTIGEN; HLA B ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 15; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE EXACERBATION; GENE EXPRESSION; HEREDITY; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NONHUMAN; PROSPECTIVE STUDY; REVIEW; RHEUMATOID ARTHRITIS; SEROPREVALENCE; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VIRUS ENTRY; AUTOIMMUNE DISEASES; CELLULAR IMMUNITY; COMPLICATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; IMMUNOLOGY; PATHOLOGY;

AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNITY, CELLULAR; MOLECULAR MIMICRY;

EID: 84901287771     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/472978     Document Type: Review

References (166)

1. Ascherio A., Munger K. L., Lennette E. T., Spiegelman D., Hernán M. A., Olek M. J., Hankinson S. E., Hunter D. J., Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. Journal of the American Medical Association 2001 286 24 3083 3088 2-s2.0-0035956494 (Pubitemid 34016522)
2. Hengel H., Brune W., Koszinowski U. H., Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist. Trends in Microbiology 1998 6 5 190 197 2-s2.0-0032077622 10.1016/S0966-842X(98)01255-4 (Pubitemid 28239851)
3. Babić M., Krmpotić A., Jonjić S., All is fair in virus-host interactions: NK cells and cytomegalovirus. Trends in Molecular Medicine 2011 17 11 677 685 2-s2.0-80755172251 10.1016/j.molmed.2011.07.003
4. Amsler L., Verweij M. C., DeFilippis V. R., The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. Journal of Molecular Biology 2013 425 24 4857 4871 10.1016/j.jmb.2013.08.023
5. McSharry B. P., Avdic S., Slobedman B., Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation. Viruses 2012 4 11 2448 2470 10.3390/v4112448
6. Stern-Ginossar N., Weisburd B., Michalski A., Decoding human cytomegalovirus. Science 2012 338 1088 1093 10.1126/science.1227919
7. Sinzger C., Grefte A., Plachter B., Gouw A. S. H., Hauw The T., Jahn G., Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. Journal of General Virology 1995 76 4 741 750 2-s2.0-0028907911
8. Ji Y. N., An L., Zhan P., Chen X. H., Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. Molecular Biology Reports 2012 39 6 6537 6546 10.1007/s11033-012-1482-6
9. Pawelec G., McElhaney J. E., Aiello A. E., Derhovanessian E., The impact of CMV infection on survival in older humans. Current Opinion in Immunology 2012 24 507 511 2-s2.0-84860142913 10.1016/j.coi.2012.04.002
10. Cobbs C. S., Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects. Current Opinion on Oncology 2013 25 682 688 10.1097/CCO.0000000000000005
11. Fujinami R. S., Oldstone M. B., Wroblewska Z., Frankel M. E., Koprowski H., Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proceedings of the National Academy of Sciences of the United States of America 1983 80 8 2346 2350 2-s2.0-0020560134 (Pubitemid 13097186)
12. Zabriskie J. B., Freimer E. H., An immunological relationship between the group. A streptococcus and mammalian muscle. Journal of Experimental Medicine 1966 124 4 661 678 2-s2.0-0013963570
13. Rose N. R., Mackay I. R., Molecular mimicry: a critical look at exemplary instances in human diseases. Cellular and Molecular Life Sciences 2000 57 4 542 551 2-s2.0-0034103383 (Pubitemid 30311425)
14. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grässer F. A., van Dyk L. F., Kiong Ho C., Shuman S., Chien M., Russo J. J., Ju J., Randall G., Lindenbach B. D., Rice C. M., Simon V., Ho D. D., Zavolan M., Tuschl T., Identification of microRNAs of the herpesvirus family. Nature Methods 2005 2 4 269 276 2-s2.0-20844463414 10.1038/nmeth746 (Pubitemid 41131008)
15. Stark T. J., Arnold J. D., Spector D. H., Yeo G. W., High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection. Journal of Virology 2012 86 1 226 235 2-s2.0-84855955654 10.1128/JVI.05903-11
16. Crough T., Khanna R., Immimobiology of human cytomegalovirus: from bench to bedside. Clinical Microbiology Reviews 2009 22 1 76 98 2-s2.0-59649121998 10.1128/CMR.00034-08
17. Ludwig A., Hengel H., Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveillance 2009 14 9 26 32 2-s2.0-66649103750
18. Presti R. M., Pollock J. L., Dal Canto A. J., O'Guin A. K., Virgin H. W., Interferon γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. Journal of Experimental Medicine 1998 188 3 577 588 2-s2.0-0032479923 10.1084/jem.188.3.577 (Pubitemid 28369146)
19. Polić B., Hengel H., Krmpotić A., Trgovcich J., Pavić I., Lučin P., Jonjić S., Koszinowski U. H., Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. Journal of Experimental Medicine 1998 188 6 1047 1054 2-s2.0-0032555912 10.1084/jem.188.6.1047 (Pubitemid 28443328)
20. Reddehase M. J., Erratum: the immunogenicity of human and murine cytomegaloviruses. Current Opinion in Immunology 2000 12 6 738 2-s2.0-0033739283 10.1016/S0952-7915(00)00171-0
21. Sylwester A. W., Mitchell B. L., Edgar J. B., Taormina C., Pelte C., Ruchti F., Sleath P. R., Grabstein K. H., Hosken N. A., Kern F., Nelson J. A., Picker L. J., Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. Journal of Experimental Medicine 2005 202 5 673 685 2-s2.0-24344489044 10.1084/jem.20050882 (Pubitemid 41248418)
22. Ouyang Q., Wagner W. M., Wikby A., Walter S., Aubert G., Dodi A. I., Travers P., Pawelec G., Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. Journal of Clinical Immunology 2003 23 4 247 257 2-s2.0-0037825764 10.1023/A:1024580531705 (Pubitemid 36870667)
23. van Leeuwen E. M. M., Remmerswaal E. B. M., Vossen M. T. M., Rowshani A. T., Wertheim-Van Dillen P. M. E., van Lier R. A. W., ten Berge I. J. M., Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. Journal of Immunology 2004 173 3 1834 1841 2-s2.0-3242748853 (Pubitemid 38971617)
24. Wikby A., Johansson B., Olsson J., Löfgren S., Nilsson B.-O., Ferguson F., Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Experimental Gerontology 2002 37 2-3 445 453 2-s2.0-0037012021 10.1016/S0531-5565(01)00212-1 (Pubitemid 34073563)
25. Turner J. E., Campbell J. P., Edwards K. M., Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age 2014 36 287 297 10.1007/s11357-013-9557-4
26. Gumá M., Angulo A., Vilches C., Gómez-Lozano N., Malats N., López-Botet M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004 104 12 3664 3671 2-s2.0-9444273448 10.1182/blood-2004-05-2058 (Pubitemid 39564443)
27. Gumá M., Budt M., Sáez A., Brckalo T., Hengel H., Angulo A., López-Botet M., Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006 107 9 3624 3631 2-s2.0-33646422721 10.1182/blood-2005-09-3682
28. Beziat V., Liu L. L., Malmberg J. A., NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013 121 2678 2688 10.1182/blood-2012-10- 459545
29. Charoudeh H. N., Terszowski G., Czaja K., Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. European Journal of Immunology 2013 43 2 480 487 10.1002/eji.201242389
30. Tomazin R., Boname J., Hedge N. R., Lewinsohn D. M., Altschuler Y., Jones T. R., Cresswell P., Nelson J. A., Riddell S. R., Johnson D. C., Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nature Medicine 1999 5 9 1039 1043 2-s2.0-0032863467 10.1038/12478 (Pubitemid 29439575)
31. Wiertz E. J. H. J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T. R., Rapoport T. A., Ploegh H. L., Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996 384 6608 432 438 2-s2.0-0029828991 10.1038/384432a0 (Pubitemid 26414653)
32. Johnson D. C., Hegde N. R., Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus. Current Topics in Microbiology and Immunology 2002 269 101 115 2-s2.0-0035988044 (Pubitemid 34851529)
33. Jones T. R., Wiertz E. J. H. J., Sun L., Fish K. N., Nelson J. A., Ploegh H. L., Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proceedings of the National Academy of Sciences of the United States of America 1996 93 21 11327 11333 2-s2.0-0029969098 10.1073/pnas.93.21.11327 (Pubitemid 26347121)
34. Ahn K., Gruhler A., Galocha B., Jones T. R., Wiertz E. J. H. J., Ploegh H. L., Peterson P. A., Yang Y., Früh K., The ER-luminal domain of the HCMV glypcoprotein US6 inhibits peptide translocation by TAP. Immunity 1997 6 5 613 621 2-s2.0-0030927096 10.1016/S1074-7613(00)80349-0 (Pubitemid 27239352)
35. Hengel H., Koopmann J.-O., Flohr T., Muranyi W., Goulmy E., Hämmerling G. J., Koszinowski U. H., Momburg F., A viral ER-resident glycoprotein inactivates the MHC-endoced peptide transporter. Immunity 1997 6 5 623 632 2-s2.0-0030978748 10.1016/S1074-7613(00)80350-7 (Pubitemid 27239353)
36. Jones T. R., Hanson L. K., Sun L., Slater J. S., Stenberg R. M., Campbell A. E., Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. Journal of Virology 1995 69 8 4830 4841 2-s2.0-0029074044
37. Tirabassi R. S., Ploegh H. L., The human cytomegalovirus US8 glycoprotein binds to major histocompatibility complex class I products. Journal of Virology 2002 76 13 6832 6835 2-s2.0-0036282011 10.1128/JVI.76.13.6832-6835.2002 (Pubitemid 34633549)
38. Kim Y., Park B., Cho S., Shin J., Cho K., Jun Y., Ahn K., Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses. PLoS Pathogens 2008 4 8 2-s2.0-50849088309 10.1371/journal.ppat.1000123 e1000123
39. Kim S., Lee S., Shin J., Kim Y., Evnouchidou I., Kim D., Kim Y.-K., Kim Y.-E., Ahn J.-H., Riddell S. R., Stratikos E., Kim V. N., Ahn K., Human cytomegalovirus microRNA miR-US4-1 inhibits CD8+ T cell responses by targeting the aminopeptidase ERAP1. Nature Immunology 2011 12 10 984 991 2-s2.0-80052966924 10.1038/ni.2097
40. Halenius A., Hauka S., Dölken L., Stindt J., Reinhard H., Wiek C., Hanenberg H., Koszinowski U. H., Momburg F., Hengel H., Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. Journal of Virology 2011 85 7 3473 3485 2-s2.0-79952596162 10.1128/JVI.01923-10
41. Gabaev I., Steinbrück L., Pokoyski C., Pich A., Stanton R. J., Schwinzer R., Schulz T. F., Jacobs R., Messerle M., Kay-Fedorov P. C., The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells. PLoS Pathogens 2011 7 12 2-s2.0-84855264154 10.1371/journal.ppat.1002432 e1002432
42. Dunn C., Chalupny N. J., Sutherland C. L., Dosch S., Sivakumar P. V., Johnson D. C., Cosman D., Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. Journal of Experimental Medicine 2003 197 11 1427 1439 2-s2.0-0037905745 10.1084/jem.20022059 (Pubitemid 36682542)
43. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., Hsu M.-L., A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997 7 2 273 282 2-s2.0-0030768392 10.1016/S1074-7613(00)80529-4 (Pubitemid 27392018)
44. Ulbrecht M., Martinozzi S., Grzeschik M., Hengel H., Ellwart J. W., Pla M., Weiss E. H., Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. Journal of Immunology 2000 164 10 5019 5022 2-s2.0-0034658344 (Pubitemid 30305172)
45. Bennett N. J., Ashiru O., Morgan F. J. E., Pang Y., Okecha G., Eagle R. A., Trowsdale J., Sissons J. G. P., Wills M. R., Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus. Journal of Immunology 2010 185 2 1093 1102 2-s2.0-77955483375 10.4049/jimmunol.1000789
46. Chalupny N. J., Rein-Weston A., Dosch S., Cosman D., Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochemical and Biophysical Research Communications 2006 346 1 175 181 2-s2.0-33744990829 10.1016/j.bbrc.2006.05.092 (Pubitemid 43865981)
47. Stern-Ginossar N., Elefant N., Zimmermann A., Wolf D. G., Saleh N., Biton M., Horwitz E., Prokocimer Z., Prichard M., Hahn G., Goldman-Wohl D., Greenfield C., Yagel S., Hengel H., Altuvia Y., Margalit H., Mandelboim O., Host immune system gene targeting by a viral miRNA. Science 2007 317 5836 376 381 2-s2.0-34547132780 10.1126/science.1140956 (Pubitemid 47106378)
48. Arnon T. I., Achdout H., Levi O., Markel G., Saleh N., Katz G., Gazit R., Gonen-Gross T., Hanna J., Nahari E., Porgador A., Honigman A., Plachter B., Mevorach D., Wolf D. G., Mandelboim O., Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nature Immunology 2005 6 5 515 523 2-s2.0-18244367112 10.1038/ni1190 (Pubitemid 41716765)
49. Atalay R., Zimmermann A., Wagner M., Borst E., Benz C., Messerle M., Hengel H., Identification and expression of human cytomegalovirus transcription units coding for two distinct Fc γ receptor homologs. Journal of Virology 2002 76 17 8596 8608 2-s2.0-0036333909 10.1128/JVI.76.17.8596-8608.2002 (Pubitemid 34864054)
50. Park B., Spooner E., Houser B. L., Strominger J. L., Ploegh H. L., The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. Journal of Experimental Medicine 2010 207 9 2033 2041 2-s2.0-77956255311 10.1084/jem.20091793
51. Han J., Rho S. B., Lee J. Y., Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT, (iNKT) cell activity. Molecules and Cells 2013 36 5 455 464 10.1007/s10059-013-0221-8
52. Streblow D. N., Soderberg-Naucler C., Vieira J., Smith P., Wakabayashi E., Ruchti F., Mattison K., Altschuler Y., Nelson J. A., The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999 99 5 511 520 2-s2.0-0033601104
53. Weber C., von Stülpnagel C., Weber K. S. C., Hengel H., Weber P. C., Association of myocardial infarction with mononuclear cell expression of the cytomegalovirus chemokine receptor US28 in patients with NIDDM. Experimental and Clinical Cardiology 2001 6 2 105 108 2-s2.0-0034916082 (Pubitemid 32691190)
54. Arnolds K. L., Lares A. P., Spencer J. V., The US27 gene product of human cytomegalovirus enhances signaling of host chemokine receptor CXCR4. Virology 2013 439 122 131 10.1016/j.virol.2013.02.006
55. Tadagaki K., Tudor D., Gbahou F., Human cytomegalovirus-encoded UL33 and UL78 heteromerize with host CCR5 and CXCR4 impairing their HIV coreceptor activity. Blood 2012 119 4908 4918
56. Kotenko S. V., Saccani S., Izotova L. S., Mirochnitchenko O. V., Pestka S., Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proceedings of the National Academy of Sciences of the United States of America 2000 97 4 1695 1700 2-s2.0-0034652261 10.1073/pnas.97.4.1695 (Pubitemid 30118505)
57. Spencer J. V., Cadaoas J., Castillo P. R., Saini V., Slobedman B., Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology 2008 374 1 164 169 2-s2.0-41149122453 10.1016/j.virol.2007.11.031
58. Jenkins C., Abendroth A., Slobedman B., novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. Journal of Virology 2004 78 3 1440 1447 2-s2.0-0346373693 10.1128/JVI.78.3.1440-1447.2004 (Pubitemid 38095854)
59. Lüttichau H. R., The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. The Journal of Biological Chemistry 2010 285 12 9137 9146 2-s2.0-77950584882 10.1074/jbc.M109.002774
60. Penfold M. E. T., Dairaghi D. J., Duke G. M., Saederup N., Mocarski E. S., Kemble G. W., Schall T. J., Cytomegalovirus encodes a potent α chemokine. Proceedings of the National Academy of Sciences of the United States of America 1999 96 17 9839 9844 2-s2.0-0033578433 10.1073/pnas.96.17.9839 (Pubitemid 29398819)
61. Wang D., Bresnahan W., Shenk T., Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proceedings of the National Academy of Sciences of the United States of America 2004 101 47 16642 16647 2-s2.0-9344236534 10.1073/pnas.0407233101 (Pubitemid 39557766)
62. Zheng Q., Tao R., Gao H., Xu J., Shang S., Zhao N., HCMV-encoded UL128 enhances TNF- α and IL-6 expression and promotes PBMC proliferation through the MAPK/ERK pathway in vitro. Viral Immunology 2012 25 2 98 105 2-s2.0-84859575891 10.1089/vim.2011.0064
63. Le V. T. K., Trilling M., Hengel H., The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF- α signaling. Journal of Virology 2011 85 24 13260 13270 2-s2.0-84855296602 10.1128/JVI.06005-11
64. Montag C., Wagner J. A., Gruska I., Vetter B., Wiebusch L., Hagemeier C., The latency-associated ul138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF) signaling by upregulating tnf receptor 1 cell surface expression. Journal of Virology 2011 85 21 11409 11421 2-s2.0-80055115106 10.1128/JVI.05028-11
65. Benedict C. A., Butrovich K. D., Lurain N. S., Corbeil J., Rooney I., Schneider P., Tschopp J., Ware C. F., Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. Journal of Immunology 1999 162 12 6967 6970 2-s2.0-0033564340 (Pubitemid 29277660)
66. Engel P., Pérez-Carmona N., Albà M. M., Robertson K., Ghazal P., Angulo A., Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production. Immunology and Cell Biology 2011 89 7 753 766 2-s2.0-80053903667 10.1038/icb.2011.55
67. Miller D. M., Rahill B. M., Boss J. M., Lairmore M. D., Durbin J. E., Waldman W. J., Sedmak D. D., Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. Journal of Experimental Medicine 1998 187 5 675 683 2-s2.0-0032473555 10.1084/jem.187.5.675 (Pubitemid 28115183)
68. Le V. T. K., Trilling M., Wilborn M., Hengel H., Zimmermann A., Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. Journal of General Virology 2008 89 10 2416 2426 2-s2.0-54449100076 10.1099/vir.0.2008/001669-0
69. Abate D. A., Watanabe S., Mocarski E. S., Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. Journal of Virology 2004 78 20 10995 11006 2-s2.0-4644316070 10.1128/JVI.78.20.10995-11006.2004 (Pubitemid 39299640)
70. Cassady K. A., Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection. Journal of Virology 2005 79 14 8707 8715 2-s2.0-21644460103 10.1128/JVI.79.14.8707-8715.2005 (Pubitemid 40934781)
71. Tan J. C. G., Avdic S., Cao J. Z., Mocarski E. S., White K. L., Abendroth A., Slobedman B., Inhibition of 2′5′-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product. Journal of Virology 2011 85 11 5696 5700 2-s2.0-79956065291 10.1128/JVI.02463-10
72. Paulus C., Krauss S., Nevels M., A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proceedings of the National Academy of Sciences of the United States of America 2006 103 10 3840 3845 2-s2.0-33644863208 10.1073/pnas.0600007103 (Pubitemid 43376642)
73. Taylor R. T., Bresnahan W. A., Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NF B-dependent gene expression. Journal of Virology 2006 80 21 10763 10771 2-s2.0-33750365113 10.1128/JVI.01195-06 (Pubitemid 44628922)
74. Goldmacher V. S., vMIA, a viral inhibitor of apoptosis targeting mitochondria. Biochimie 2002 84 2-3 177 185 2-s2.0-0036479010 10.1016/S0300-9084(02)01367-6
75. Skaletskaya A., Bartle L. M., Chittenden T., McCormick A. L., Mocarski E. S., Goldmacher V. S., A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proceedings of the National Academy of Sciences of the United States of America 2001 98 14 7829 7834 2-s2.0-0034933686 10.1073/pnas.141108798 (Pubitemid 32642646)
76. Zhu H., Shen Y., Shenk T., Human cytomegalovirus IE1 and IE2 proteins block apoptosis. Journal of Virology 1995 69 12 7960 7970 2-s2.0-0028801332
77. Korioth F., Maul G. G., Plachter B., Stamminger T., Frey J., The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Experimental Cell Research 1996 229 1 155 158 2-s2.0-0030602019 10.1006/excr.1996.0353 (Pubitemid 26423944)
78. Cantrell S. R., Bresnahan W. A., Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. Journal of Virology 2006 80 12 6188 6191 2-s2.0-33744908280 10.1128/JVI.02676-05 (Pubitemid 43849198)
79. Preston C. M., Nicholl M. J., Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. Journal of General Virology 2006 87 5 1113 1121 2-s2.0-33646161949 10.1099/vir.0.81566-0
80. Saffert R. T., Kalejta R. F., Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. Journal of Virology 2006 80 8 3863 3871 2-s2.0-33645757807 10.1128/JVI.80.8. 3863-3871.2006
81. Esen B. A., Yilmaz G., Uzun S., Özdamar M., Aksözek A., KamalI S., Türkolu S., Gül A., Öcal L., Aral O., Inanç M., Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study. Rheumatology International 2012 32 1 79 83 2-s2.0-84857116713 10.1007/s00296-010-1573-4
82. Pandey J. P., Immunoglobulin GM genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis. Clinical and Experimental Rheumatology 2004 22 3 S35 S37 2-s2.0-4444351075 (Pubitemid 39162033)
83. Neidhart M., Kuchen S., Distler O., Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis. Arthritis & Rheumatology 1999 42 389 392 (Pubitemid 29072859)
84. Larsen M., Sauce D., Deback C., Arnaud L., Mathian A., Miyara M., Boutolleau D., Parizot C., Dorgham K., Papagno L., Appay V., Amoura Z., Gorochov G., Exhausted cytotoxic control of epstein-barr virus in human lupus. PLoS Pathogens 2011 7 10 2-s2.0-80055082266 10.1371/journal.ppat.1002328 e1002328
85. Su B. Y.-J., Su C.-Y., Yu S.-F., Chen C.-J., Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Medical Microbiology and Immunology 2007 196 3 165 170 2-s2.0-34548130794 10.1007/s00430-007-0040-7 (Pubitemid 47300254)
86. McClain M. T., Poole B. D., Bruner B. F., Kaufman K. M., Harley J. B., James J. A., An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis & Rheumatism 2006 54 1 360 368 2-s2.0-31044433220 10.1002/art.21682 (Pubitemid 43122221)
87. Parks C. G., Cooper G. S., Hudson L. L., Dooley M. A., Treadwell E. L., St.Clair E. W., Gilkeson G. S., Pandey J. P., Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis & Rheumatism 2005 52 4 1148 1159 2-s2.0-17244368917 10.1002/art.20997 (Pubitemid 40530122)
88. James J. A., Neas B. R., Moser K. L., Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis & Rheumatism 2001 44 1122 1126 (Pubitemid 32433618)
89. Bendiksen S., van Ghelue M., Rekvig O. P., Gutteberg T., Haga H.-J., Moens U., A longitudinal study of human cytomegalovirus serology and viruria fails to detect active viral infection in 20 systemic lupus erythematosus patients. Lupus 2000 9 2 120 126 2-s2.0-0034018077 (Pubitemid 30171109)
90. Stratta P., Canavese C., Ciccone G., Santi S., Quaglia M., Ghisetti V., Marchiaro G., Barbui A., Fop F., Cavallo R., Piccoli G., Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis. Nephron 1999 82 2 145 154 2-s2.0-0032989837 10.1159/000045391 (Pubitemid 29263974)
91. Rider J. R., Ollier W. E. R., Lock R. J., Brookes S. T., Pamphilon D. H., Human cytomegalovirus infection and systemic lupus erythematosus. Clinical and Experimental Rheumatology 1997 15 4 405 409 2-s2.0-0030764761 (Pubitemid 27324003)
92. James J. A., Kaufman K. M., Farris A. D., Taylor-Albert E., Lehman T. J. A., Harley J. B., An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. Journal of Clinical Investigation 1997 100 12 3019 3026 2-s2.0-0031465706 (Pubitemid 28022839)
93. Aarnisalo J., Veijola R., Vainionpää R., Simell O., Knip M., Ilonen J., Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes. Diabetologia 2008 51 5 769 772 2-s2.0-41849130627 10.1007/s00125-008-0945-8
94. Hiltunen M., Hyoty H., Karjalainen J., Leinikki P., Knip M., Lounamaa R., Akerblom H. K., Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM: a prospective study. Diabetologia 1995 38 6 705 710 2-s2.0-0029025697 10.1007/s001250050341
95. Sundqvist E., Bergstrom T., Daialhosein H., Cytomegalovirus seropositivity is negatively associated with multiple sclerosis. Multiple Sclerosis Journal 2013 10.1177/1352458513494489
96. Sanadgol N., Ramroodi N., Ahmadi G. A., Komijani M., Moghtaderi A., Bouzari M., Rezaei M., Kardi M. T., Dabiri S., Moradi M., Sanadgol E., Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis. New Microbiologica 2011 34 3 263 274 2-s2.0-84860397764
97. Waubant E., Mowry E. M., Krupp L., Chitnis T., Yeh E. A., Kuntz N., Ness J., Chabas D., Strober J., McDonald J., Belman A., Milazzo M., Gorman M., Weinstock-Guttman B., Rodriguez M., Oksenberg J. R., James J. A., Common viruses associated with lower pediatric multiple sclerosis risk. Neurology 2011 76 23 1989 1995 2-s2.0-79958758673 10.1212/WNL.0b013e31821e552a
98. Myhr K.-M., Riise T., Barrett-Connor E., Myrmel H., Vedeler C., Grønning M., Kalvenes M. B., Nyland H., Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: A population based case-control study from western Norway. Journal of Neurology Neurosurgery and Psychiatry 1998 64 4 539 542 2-s2.0-0031967440 (Pubitemid 28195960)
99. Gutiérrez J., Vergara M.-J., Guerrero M., Fernández O., Piédrola G., Morales P., Del C. Maroto M., Multiple sclerosis and human herpesvirus 6. Infection 2002 30 3 145 149 2-s2.0-0035989984 10.1007/s15010-002-2056-7 (Pubitemid 34606709)
100. Pierer M., Rothe K., Quandt D., Association of anticytomegalovirus seropositivity with more severe joint destruction and more frequent joint surgery in rheumatoid arthritis. Arthritis & Rheumatism 2012 64 1740 1749
101. Thomas D., Karachaliou F., Kallergi K., Vlachopapadopoulou E., Antonaki G., Chatzimarkou F., Fotinou A., Kaldrymides P., Michalacos S., Herpes virus antibodies seroprevalence in children with autoimmune thyroid disease. Endocrine 2008 33 2 171 175 2-s2.0-49649098215 10.1007/s12020-008-9068-8
102. Scully C., Sjogren's syndrome: No demonstrable association by serology of secondary sjorgen's syndrome with cytomegalovirus. Journal of Oral Pathology and Medicine 1990 19 1 43 44 2-s2.0-0025192248 (Pubitemid 20128765)
103. Arnson Y., Amital H., Guiducci S., Matucci-Cerinic M., Valentini G., Barzilai O., Maya R., Shoenfeld Y., The role of infections in the immunopathogensis of systemic sclerosis-evidence from serological studies. Annals of the New York Academy of Sciences 2009 1173 627 632 2-s2.0-69949121675 10.1111/j.1749-6632.2009.04808.x
104. Vaughan J. H., Shaw P. X., Nguyen M.-D., Medsger T.A. J., Wright T. M., Metcalf J. S., Leroy E. C., Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. Journal of Rheumatology 2000 27 3 821 823 2-s2.0-0034098844 (Pubitemid 30151374)
105. Barzilai O., Sherer Y., Ram M., Izhaky D., Anaya J. M., Shoenfeld Y., Epstein-Barr virus and cytomegalovirus in autoimmune diseases: Are they truly notorious? A preliminary report. Annals of the New York Academy of Sciences 2007 1108 567 577 2-s2.0-34948875236 10.1196/annals.1422.059 (Pubitemid 47528770)
106. Palafox Sánchez C. A., Satoh M., Chan E. K., Carcamo W. C., Muñoz Valle J. F., Orozco Barocio G., Oregon Romero E., Navarro Hernández R. E., Salazar Páramo M., Cabral Castañeda A., Vázquez Del Mercado M., Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies. Arthritis Research & Therapy 2009 11 1 R27 2-s2.0-70149117381
107. Ivarsson S.-A., Lindberg B., Nilsson K. O., Ahlfors K., Svanberg L., The prevalence of Type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus. Diabetic Medicine 1993 10 6 521 523 2-s2.0-0027223472 (Pubitemid 23189755)
108. Ward K. P., Galloway W. H., Auchterlonie I. A., Congenital cytomegalovirus infection and diabetes. The Lancet 1979 1 8114 497 2-s2.0-0018780417
109. Pak C. Y., McArthur R. G., Eun H.-M., Yoon J.-W., Association of cytomegalovirus infection with autoimmune type 1 diabetes. The Lancet 1988 2 8601 1 4 2-s2.0-0023950172
110. Zivadinov R., Nasuelli D., Tommasi M. A., Serafin M., Bratina A., Ukmar M., Pirko I., Johnson A. J., Furlan C., Pozzi-Mucelli R. S., Monti-Bragadin L., Grop A., Zambon M., Antonello R. M., Cazzato G., Zorzon M., Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurological Research 2006 28 3 262 269 2-s2.0-33646816323 10.1179/016164106X98134 (Pubitemid 43765110)
111. Pirko I., Cardin R., Chen Y., Lohrey A. K., Lindquist D. M., Dunn R. S., Zivadinov R., Johnson A. J., CMV infection attenuates the disease course in a murine model of multiple sclerosis. PLoS ONE 2012 7 2 2-s2.0-84857662473 10.1371/journal.pone.0032767 e32767
112. Shillitoe E. J., Daniels T. E., Whitcher J. P., Antibody to cytomegalovirus in patients with Sjogren's syndrome. As determined by an enzyme-linked immunosorbent assay. Arthritis & Rheumatism 1982 25 3 260 265 2-s2.0-0020063830 (Pubitemid 12100375)
113. Ferri C., Cazzato M., Giuggioli D., Sebastiani M., Magro C., Systemic sclerosis following human cytomegalovirus infection. Annals of the Rheumatic Diseases 2002 61 10 937 938 2-s2.0-0036786905 10.1136/ard.61.10.937
114. Hayashi T., Lee S., Ogasawara H., Sekigawa I., Lida N., Tomino Y., Hashimoto H., Hirose S., Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus 1998 7 8 561 564 2-s2.0-0031773385 (Pubitemid 28542635)
115. Nawata M., Seta N., Yamada M., Sekigawa I., Iida N., Hashimoto H., Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus. Scandinavian Journal of Rheumatology 2001 30 6 360 362 2-s2.0-0035668174 10.1080/030097401317148570 (Pubitemid 34001541)
116. Pérez-Mercado A. E., Vilá-Pérez S., Cytomegalovirus as a trigger for systemic lupus erythematosus. Journal of Clinical Rheumatology 2010 16 7 335 337 2-s2.0-78049291275 10.1097/RHU.0b013e3181f4cf52
117. Cusick M. F., Libbey J. E., Fujinami R. S., Molecular mimicry as a mechanism of autoimmune disease. Clinical Reviews in Allergy and Immunology 2012 42 1 102 111 2-s2.0-84857061618 10.1007/s12016-011-8294-7
118. Zhao Z.-S., Granucci F., Yeh L., Schaffer P. A., Cantor H., Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998 279 5355 1344 1347 2-s2.0-0032570826 10.1126/science.279.5355.1344 (Pubitemid 28119574)
119. Deshpande S., Zheng M., Lee S., Banerjee K., Gangappa S., Kumaraguru U., Rouse B. T., Bystander activation involving T lymphocytes in herpetic stromal keratitis. Journal of Immunology 2001 167 5 2902 2910 2-s2.0-0035451354 (Pubitemid 32768925)
120. Horwitz M. S., La Cava A., Fine C., Rodriguez E., Ilic A., Sarvetnick N., Pancreatic expression of interferon- γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nature Medicine 2000 6 6 693 697 2-s2.0-0034086692 10.1038/76277 (Pubitemid 30398795)
121. Münz C., Lünemann J. D., Getts M. T., Miller S. D., Antiviral immune responses: Triggers of or triggered by autoimmunity? Nature Reviews Immunology 2009 9 4 246 258 2-s2.0-63149158618 10.1038/nri2527
122. Murphy E., Yu D., Grimwood J., Schmutz J., Dickson M., Jarvis M. A., Hahn G., Nelson J. A., Myers R. M., Shenk T. E., Coding potential of laboratory and clinical strains of human cytomegalovirus. Proceedings of the National Academy of Sciences of the United States of America 2003 100 25 14976 14981 2-s2.0-10744225986 10.1073/pnas.2136652100 (Pubitemid 37518002)
123. Hu P. Q., Fertig N., Medsger T. A. Jr., Wright T. M., Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis & Rheumatism 2003 48 5 1363 1373 2-s2.0-0037653223 10.1002/art.10977 (Pubitemid 36554535)
124. Lunardi C., Bason C., Navone R., Millo E., Damonte G., Corrocher R., Puccetti A., Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nature Medicine 2000 6 10 1183 1186 2-s2.0-0033790892 10.1038/80533
125. Lunardi C., Dolcino M., Peterlana D., Bason C., Navone R., Tamassia N., Beri R., Corrocher R., Puccetti A., Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Medicine 2006 3 1 e2 2-s2.0-32044456248 10.1371/journal.pmed.0030002 (Pubitemid 43200636)
126. Namboodiri A. M., Rocca K. M., Pandey J. P., IgG antibodies to human cytomegalovirus late protein UL94 in patients with systematic sclerosis. Autoimmunity 2004 37 3 241 244 2-s2.0-4444272283 10.1080/08916930410001710046 (Pubitemid 39162682)
127. Muryoi T., Kasturi K. N., Kafina M. J., Cram D. S., Harrison L. C., Sasaki T., Bona C. A., Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes. Journal of Experimental Medicine 1992 175 4 1103 1109 2-s2.0-0026588370
128. Pandey J. P., LeRoy E. C., Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis & Rheumatism 1998 41 10 15 (Pubitemid 28041917)
129. Hamamdzic D., Harley R. A., Hazen-Martin D., LeRoy E. C., MCMV induces neointima in IFN- γ R-/- mice: Intimal cell apoptosis and persistent proliferation of myofibroblasts. BMC Musculoskeletal Disorders 2001 2, article 3 2-s2.0-3142581897 10.1186/1471-2474-2-1
130. Arbuckle M. R., McClain M. T., Rubertone M. V., Hal Scofield R., Dennis G. J., James J. A., Harley J. B., Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England Journal of Medicine 2003 349 16 1526 1533 2-s2.0-0142009533 10.1056/NEJMoa021933 (Pubitemid 37255038)
131. Ramos-Casals M., Cuadrado M. J., Alba P., Sanna G., Brito-Zerón P., Bertolaccini L., Babini A., Moreno A., D'Cruz D., Khamashta M. A., Acute viral infections in patients with systemic lupus erythematosus: Description of 23 cases and review of the literature. Medicine 2008 87 6 311 318 2-s2.0-58149190134 10.1097/MD.0b013e31818ec711
132. Chang M., Pan M.-R., Chen D.-Y., Lan J.-L., Human cytomegalovirus pp65 lower matrix protein: A humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice. Clinical and Experimental Immunology 2006 143 1 167 179 2-s2.0-33644825842 10.1111/j.1365-2249.2005.02974.x
133. Hsieh A.-H., Jhou Y.-J., Liang C.-T., Chang M., Wang S.-L., Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice. Arthritis Research & Therapy 2011 13 R162 2-s2.0-80053896986 10.1186/ar3481
134. Curtis H. A., Singh T., Newkirk M. M., Recombinant cytomegalovirus glycoprotein gB (UL55) induces an autoantibody response to the U1-70 kDa small nuclear ribonucleoprotein. European Journal of Immunology 1999 29 3643 3653 10.1002/(SICI)1521-4141(199911)29:11<3643::AID-IMMU3643>3.0. CO;2-J (Pubitemid 29527813)
135. Newkirk M. M., van Venrooij W. J., Marshall G. S., Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection. Arthritis Research 2001 3 4 253 258 2-s2.0-0034946636 10.1186/ar310 (Pubitemid 32621965)
136. Marshall B. C., McPherson R. A., Greidinger E., Hoffman R., Adler S. P., Lack of autoantibody production associated with cytomegalovirus infection. Arthritis Research 2002 4, article R6
137. Schleiss M. R., Bernstein D. I., Passo M., Parker S., Meric C., Verdier F., Newkirk M. M., Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects. Vaccine 2004 23 5 687 692 2-s2.0-8144226828 10.1016/j.vaccine.2004.06.038 (Pubitemid 39473200)
138. Jenson A. B., Rosenberg H. S., Notkins A. L., Pancreatic islet-cell damage in children with fatal viral infections. The Lancet 1980 2 8190 354 358 2-s2.0-0019327043
139. Foulis A. K., McGill M., Farquharson M. A., Hilton D. A., A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 1997 40 1 53 61 2-s2.0-0031033558 10.1007/s001250050642 (Pubitemid 27035710)
140. Smelt M. J., Faas M. M., de Haan B. J., Draijer C., Hugenholtz G. C. G., De Haan A., Engelse M. A., De Koning E. J. P., De Vos P., Susceptibility of human pancreatic β cells for cytomegalovirus infection and the effects on cellular immunogenicity. Pancreas 2012 41 1 39 49 2-s2.0-84655169665 10.1097/MPA.0b013e31821fc90c
141. Pak C. Y., Cha C. Y., Rajotte R. V., McArthur R. G., Yoon J. W., Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia 1990 33 9 569 572 2-s2.0-0025075154 10.1007/BF00404146 (Pubitemid 20293165)
142. Roep B. O., The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 2003 46 3 305 321 2-s2.0-0038303191 (Pubitemid 36547585)
143. Todd J. A., Walker N. M., Cooper J. D., Smyth D. J., Downes K., Plagnol V., Bailey R., Nejentsev S., Field S. F., Payne F., Lowe C. E., Szeszko J. S., Hafler J. P., Zeitels L., Yang J. H. M., Vella A., Nutland S., Stevens H. E., Schuilenburg H., Coleman G., Maisuria M., Meadows W., Smink L. J., Healy B., Burren O. S., Lam A. A. C., Ovington N. R., Allen J., Adlem E., Leung H.-T., Wallace C., Howson J. M. M., Guja C., Ionescu-Tîrgovişte C., Simmonds M. J., Heward J. M., Gough S. C. L., Dunger D. B., Wicker L. S., Clayton D. G., Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genetics 2007 39 7 857 864 2-s2.0-34347341846 10.1038/ng2068 (Pubitemid 47018195)
144. Hiemstra H. S., Schloot N. C., van Veelen P. A., Willemen S. J. M., Franken K. L. M. C., Van Rood J. J., De Vries R. R. P., Chaudhuri A., Behan P. O., Drijfhout J. W., Roep B. O., Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 3988 3991 2-s2.0-0035957438 10.1073/pnas.071050898 (Pubitemid 32249885)
145. Walton S., Mandaric S., Oxenius A., CD4 T cell responses in latent and chronic viral infections. Frontiers in Immunology 2013 4, article 105
146. van Leeuwen E. M. M., Remmerswaal E. B. M., Heemskerk M. H. M., ten Berge I. J. M., van Lier R. A. W., Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. Blood 2006 108 9 3121 3127 2-s2.0-33751169354 10.1182/blood-2006-03-006809
147. Fasth A. E. R., Cao D., van Vollenhoven R., Trollmo C., Malmström V., CD28nullCD4+ T cells-Characterization of an effector memory T-cell population in patients with rheumatoid arthritis. Scandinavian Journal of Immunology 2004 60 1 199 208 2-s2.0-3242669036 10.1111/j.0300-9475.2004.01464.x (Pubitemid 38943068)
148. Thewissen M., Somers V., Hellings N., Fraussen J., Damoiseaux J., Stinissen P., CD4+CD28null T cells in autoimmune disease: Pathogenic features and decreased susceptibility to immunoregulation. Journal of Immunology 2007 179 10 6514 6523 2-s2.0-38449099960
149. Markovic-Plese S., Cortese I., Wandinger K.-P., McFarland H. F., Martin R., CD4+CD28- costimulation-independent T cells in multiple sclerosis. Journal of Clinical Investigation 2001 108 8 1185 1194 2-s2.0-0034773579 10.1172/JCI200112516 (Pubitemid 32995377)
150. Komocsi A., Lamprecht P., Csernok E., Mueller A., Holl-Ulrich K., Seitzer U., Moosig F., Schnabel A., Gross W. L., Peripheral blood and granuloma CD4+CD28- T cells are a major source of interferon- γ and tumor necrosis factor- α in Wegener's granulomatosis. American Journal of Pathology 2002 160 5 1717 1724 2-s2.0-0036097722 (Pubitemid 34525651)
151. Eriksson P., Sandell C., Backteman K., Ernerudh J., Expansions of CD4+CD28- and CD8+CD28- T cells in granulomatosis with polyangiitis and microscopic polyangiitis are associated with cytomegalovirus infection but not with disease activity. The Journal of Rheumatology 2012 39 1840 1843 10.3899/jrheum.120060
152. Hooper M., Kallas E. G., Coffin D., Campbell D., Evans T. G., Looney R. J., Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. Journal of Rheumatology 1999 26 7 1452 1457 2-s2.0-0033013522 (Pubitemid 29317864)
153. Thewissen M., Somers V., Venken K., Linsen L., Van Paassen P., Geusens P., Damoiseaux J., Stinissen P., Analyses of immunosenescent markers in patients with autoimmune disease. Clinical Immunology 2007 123 2 209 218 2-s2.0-34247108103 10.1016/j.clim.2007.01.005 (Pubitemid 46590073)
154. Gerli R., Schillaci G., Giordano A., Bocci E. B., Bistoni O., Vaudo G., Marchesi S., Pirro M., Ragni F., Shoenfeld Y., Mannarino E., CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004 109 22 2744 2748 2-s2.0-2942547418 10.1161/01.CIR.0000131450.66017.B3 (Pubitemid 38737922)
155. Pawlik A., Ostanek L., Brzosko I., Brzosko M., Masiuk M., Machalinski B., Gawronska-Szklarz B., The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis. Arthritis Research & Therapy 2003 5 4 R210 213 2-s2.0-0242304090
156. Schmidt D., Goronzy J. J., Weyand C. M., CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. Journal of Clinical Investigation 1996 97 9 2027 2037 2-s2.0-0029958821 (Pubitemid 26143956)
157. Tovar-Salazar A., Patterson-Bartlett J., Jesser R., Weinberg A., Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells. Virology 2010 398 2 158 167 2-s2.0-75849128842 10.1016/j.virol.2009.11.038
158. Goronzy J. J., Matteson E. L., Fulbright J. W., Warrington K. J., Chang-Miller A., Hunder G. G., Mason T. G., Nelson A. M., Valente R. M., Crowson C. S., Erlich H. A., Reynolds R. L., Swee R. G., O'Fallon W. M., Weyand C. M., Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis & Rheumatism 2004 50 1 43 54 2-s2.0-9144259305 10.1002/art.11445 (Pubitemid 38084286)
159. Martens P. B., Goronzy J. J., Schaid D., Weyand C. M., Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis & Rheumatism 1997 40 6 1106 1114 2-s2.0-0030980997 10.1002/art.1780400615 (Pubitemid 27242298)
160. van Bergen J., van Gaalen F. A., van Dongen H., Anticytomegalovirus seropositivity in rheumatoid arthritis is not associated with the presence of severe extraarticular complications. Arthritis & Rheumatism 2012 64 2803 2805
161. Scotet E., Peyrat M.-A., Saulquin X., Retiere C., Couedel C., Davodeau F., Dulphy N., Toubert A., Bignon J.-D., Lim A., Vie H., Hallet M.-M., Liblau R., Weber M., Berthelot J.-M., Houssaint E., Bonneville M., Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: Towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. European Journal of Immunology 1999 29 3 973 985 2-s2.0-0032985551 (Pubitemid 29119078)
162. Griffiths S. J., Riddell N. E., Masters J., Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA. The Journal of Immunology 2013 190 5363 5372
163. Kim H.-R., Hwang K.-A., Park S.-H., Kang I., IL-7 and IL-15: biology and roles in T-cell immunity in health and disease. Critical Reviews in Immunology 2008 28 4 325 339 2-s2.0-55349112529
164. Rist M., Smith C., Bell M. J., Burrows S. R., Khanna R., Cross-recognition of HLADR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition. Blood 2009 114 11 2244 2253 2-s2.0-70349569997 10.1182/blood-2009-05-222596
165. Hansen S. G., Sacha J. B., Hughes C. M., Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 2013 340 123787
166. Michelson S., Alcami J., Kim S.-J., Danielpour D., Bachelerie F., Picard L., Bessia C., Paya C., Virelizier J.-L., Human cytomegalovirus infection induces transcription and secretion of transforming growth factor β 1. Journal of Virology 1994 68 9 5730 5737 2-s2.0-0028136715 (Pubitemid 24258588)